Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sawako Uchida-Kobayashi

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Hepatology International|April 11, 2026
From dietary patterns to metabolic phenotypes in MASLD: promise and cautionHiroko Ikenaga, Hideki Fujii, Sawako Uchida-Kobayashi
Gastroenterology|August 25, 2025
Abdominal Ultrasound Training for Gastroenterologists in Asia: Considerations and Sample ProgramSawako Uchida-Kobayashi, Winnie Chiu Wing Chu, Norifumi Kawada
Clinical Nuclear Medicine|March 30, 2026
Gallium-67 SPECT/CT Detection of Lower Extremity Muscle Abscess in Vibrio vulnificus InfectionKohei Kotani, Etsushi Kawamura, Atsushi Yoshida, et al.
Journal of Medical Ultrasonics (2001)|August 28, 2016
Development of ultrasound-assisted fluorescence imaging of indocyanine greenHiroyasu Morikawa, Shin Toyota, Kenji Wada, et al.
Clinical Journal of Gastroenterology|November 18, 2018
Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virusMasako Okada, Hoang Hai, Akihiro Tamori, et al.
Multiple Sclerosis and Related Disorders|April 8, 2020
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitisHiroko Kimura, Akitoshi Takeda, Takayuki Kikukawa, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2021
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy FailedAyami Nonomura, Akihiro Tamori, Hoang Hai, et al.
Journal of Gastroenterology|August 3, 2025
Defining optimal fatty liver index thresholds for MASLD and MetALD using controlled attenuation parameter as referenceHideki Fujii, Sawako Uchida-Kobayashi, Atsushi Kanamori, et al.
Anticancer Research|December 1, 2022
Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular CarcinomaMasahito Shibano, Katsuyuki Takahashi, Masaya Takahashi, et al.
The American Journal of Gastroenterology|May 13, 2021
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular CarcinomaKohei Kotani, Sawako Uchida-Kobayashi, Kanako Yoshida, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Hepatology International|April 11, 2026
From dietary patterns to metabolic phenotypes in MASLD: promise and cautionHiroko Ikenaga, Hideki Fujii, Sawako Uchida-Kobayashi
Gastroenterology|August 25, 2025
Abdominal Ultrasound Training for Gastroenterologists in Asia: Considerations and Sample ProgramSawako Uchida-Kobayashi, Winnie Chiu Wing Chu, Norifumi Kawada
Clinical Nuclear Medicine|March 30, 2026
Gallium-67 SPECT/CT Detection of Lower Extremity Muscle Abscess in Vibrio vulnificus InfectionKohei Kotani, Etsushi Kawamura, Atsushi Yoshida, et al.
Journal of Medical Ultrasonics (2001)|August 28, 2016
Development of ultrasound-assisted fluorescence imaging of indocyanine greenHiroyasu Morikawa, Shin Toyota, Kenji Wada, et al.
Clinical Journal of Gastroenterology|November 18, 2018
Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virusMasako Okada, Hoang Hai, Akihiro Tamori, et al.
Multiple Sclerosis and Related Disorders|April 8, 2020
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitisHiroko Kimura, Akitoshi Takeda, Takayuki Kikukawa, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2021
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy FailedAyami Nonomura, Akihiro Tamori, Hoang Hai, et al.
Journal of Gastroenterology|August 3, 2025
Defining optimal fatty liver index thresholds for MASLD and MetALD using controlled attenuation parameter as referenceHideki Fujii, Sawako Uchida-Kobayashi, Atsushi Kanamori, et al.
Anticancer Research|December 1, 2022
Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular CarcinomaMasahito Shibano, Katsuyuki Takahashi, Masaya Takahashi, et al.
The American Journal of Gastroenterology|May 13, 2021
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular CarcinomaKohei Kotani, Sawako Uchida-Kobayashi, Kanako Yoshida, et al.
Pageof 8